MedTrace Logo

Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM)

NCT00488501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2009-11-10

No results posted yet for this study

Summary

In this study we investigate the clinical value and efficacy of OptiVol (TM) impedance measurements by Medtronic (R) ICD's. We aim to determine sensitivity and positive predictive value for detecting heart failure. We also investigate if left ventricular filling pattern measured by echocardiography and/or brain natriuretic peptide (BNP) level can be used to improve the positive predictive value of the Optivol alert

Conditions

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Catharina Ziekenhuis Eindhoven

    lead OTHER

Principal Investigators

  • P Houthuizen, MD · Catharina Ziekenhuis Eindhoven

  • A Meijer, MD PhD · Catharina Ziekenhuis Eindhoven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-12-31
Completion
2009-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488501 on ClinicalTrials.gov